Gossamer Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	53.29	48.47	114.7	-	-	-
Revenue Growth	32.43%	-57.74%	-	-	-	-
Gross Profit	53.29	48.47	114.7	-	-	-
Selling, General & Admin	47.94	37.63	36.13	38.46	47.61	45.78
Research & Development	163.96	174.09	138.49	135.3	170.92	170.27
Operating Expenses	211.9	211.72	174.62	173.76	218.53	216.05
Operating Income	-158.62	-163.25	-59.92	-173.76	-218.53	-216.05
Interest Expense	-10.96	-10.99	-11.52	-13.51	-13.88	-19.44
Interest & Investment Income	1.76	1.97	1.78	2	1.58	0.76
Other Non Operating Income (Expenses)	0.26	3.41	0.96	6.01	0.11	1.14
EBT Excluding Unusual Items	-167.56	-168.86	-68.7	-179.27	-230.72	-233.59
Gain (Loss) on Sale of Investments	7.28	7.28	13.06	9.45	1.41	-0.34
Other Unusual Items	42.45	-1.4	-	-	-	-
Pretax Income	-125.31	-170.46	-55.64	-179.82	-229.38	-234
Income Tax Expense	-0.09	-0.09	0.89	-	-	-
Net Income	-125.22	-170.37	-56.53	-179.82	-229.38	-234
Net Income to Common	-125.22	-170.37	-56.53	-179.82	-229.38	-234
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	254	229	226	153	85	75
Shares Outstanding (Diluted)	254	229	226	153	85	75
Shares Change	11.86%	1.01%	48.23%	80.46%	13.00%	9.24%
EPS (Basic)	-0.49	-0.75	-0.25	-1.18	-2.71	-3.13
EPS (Diluted)	-0.65	-0.75	-0.25	-1.18	-2.71	-3.13
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-162.63	-171.35	-3.47	-159.16	-187.44	-190.44
Free Cash Flow Per Share	-0.64	-0.75	-0.01	-1.04	-2.22	-2.54
Gross Margin	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-297.67%	-336.81%	-52.24%	-	-	-
Profit Margin	-235.00%	-351.49%	-49.28%	-	-	-
Free Cash Flow Margin	-305.19%	-353.50%	-3.02%	-	-	-
EBITDA	-158.6	-163.23	-59.09	-172.15	-216.7	-214.31
EBITDA Margin	-297.63%	-	-51.51%	-	-	-
D&A For EBITDA	0.02	0.02	0.83	1.61	1.83	1.74
EBIT	-158.62	-163.25	-59.92	-173.76	-218.53	-216.05
EBIT Margin	-297.67%	-	-52.24%	-	-	-
Revenue as Reported	53.29	48.47	114.7	-	-	-

SEC Filings: 10-K · 10-Q